Stock Research for SIGA

SIGA

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

SIGA Stock Chart & Research Data

The SIGA chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the SIGA chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


SIGA Due diligence Resources & Stock Charts

The SIGA stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View SIGA Detailed Price Forecast - CNN Money CNN View SIGA Detailed Summary - Google Finance
Yahoo View SIGA Detailed Summary - Yahoo! Finance Zacks View SIGA Stock Research & Analysis - Zacks.com


Stock Analysis

TradeIdeas View SIGA Trends & Analysis - Trade-Ideas Barrons View SIGA Major Holders - Barrons
NASDAQ View SIGA Call Transcripts - NASDAQ Seeking View SIGA Breaking News & Analysis - Seeking Alpha
Spotlight View SIGA Annual Report - CompanySpotlight.com OTC Report View SIGA OTC Short Report - OTCShortReport.com
TradeKing View SIGA Fundamentals - TradeKing Charts View SIGA SEC Filings - Bar Chart
WSJ View Historical Prices for SIGA - The WSJ Morningstar View Performance/Total Return for SIGA - Morningstar
MarketWatch View the Analyst Estimates for SIGA - MarketWatch CNBC View the Earnings History for SIGA - CNBC
StockMarketWatch View the SIGA Earnings - StockMarketWatch MacroAxis View SIGA Buy or Sell Recommendations - MacroAxis
Bullish View the SIGA Bullish Patterns - American Bulls Short Pains View SIGA Short Pain Metrics - ShortPainBot.com


Social Media Mentions

StockTwits View SIGA Stock Mentions - StockTwits PennyStocks View SIGA Stock Mentions - PennyStockTweets
Twitter View SIGA Stock Mentions - Twitter Invest Hub View SIGA Investment Forum News - Investor Hub
Yahoo View SIGA Stock Mentions - Yahoo! Message Board Seeking Alpha View SIGA Stock Mentions - Seeking Alpha






Financial & Transaction Holdings

SECform4 View Insider Transactions for SIGA - SECform4.com Insider Cow View Insider Transactions for SIGA - Insider Cow
CNBC View SIGA Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for SIGA - OTC Markets
Yahoo View Insider Transactions for SIGA - Yahoo! Finance NASDAQ View Institutional Holdings for SIGA - NASDAQ


Stock Charts

FinViz View SIGA Stock Insight & Charts - FinViz.com StockCharts View SIGA Investment Charts - StockCharts.com
BarChart View SIGA Stock Overview & Charts - BarChart Trading View View SIGA User Generated Charts - Trading View


Latest Financial News for SIGA

Benzinga's Daily Biotech Pulse: Achaogen Slumps On Mixed FDA Panel Vote, Pacific Biosciences Sinks On Q1 Miss
Posted on Thursday May 03, 2018

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling the Peaks ( Stocks hitting 52-week highs on May 2 ) CASI Pharmaceuticals Inc (NASDAQ: CASI ) Eleven Biotherapeutics ...


Benzinga's Daily Biotech Pulse: SIGA Rallies On FDA Panel Backing, Rigel And Gilead React To Earnings
Posted on Wednesday May 02, 2018

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling the Peaks (Stocks hitting 52-week highs on May 1) ABIOMED, Inc. (NASDAQ: ABMD ) AveXis Inc (NASDAQ: AVXS ) (announced ...


SIGA Technologies Announces Favorable Outcome of Advisory Committee In Support of TPOXX®
Posted on Tuesday May 01, 2018

SIGA Technologies, Inc. (SIGA) (SIGA), a health security company specializing in the development and commercialization of solutions for serious unmet medical needs and biothreats, today announced a favorable outcome of the U.S. Food and Drug Administration (FDA) Antimicrobial Drugs Advisory Committee meeting on oral TPOXX®, a small molecule antiviral treatment for smallpox. The panel, comprised of independent medical experts, voted unanimously, 17 to 0, that the benefits of TPOXX outweigh its risks. “We are pleased that the advisory panel believes strongly in the benefits of TPOXX.


SIGA Technologies Stock Trading Halted Today; FDA Advisory Committee is Scheduled to Review New Drug Application of TPOXX®
Posted on Tuesday May 01, 2018

The panel, comprised of independent medical experts, will consider whether the benefits of TPOXX outweigh its risks. The FDA has previously announced that its target final action date for the oral TPOXX NDA is August 8, 2018.


Enter a stock symbol to view the stock details.